Atorvastatin downregulates plasma procarboxypeptidase U concentrations and improves fibrinolytic potential dose-dependently in hyperlipidemic individuals
Source
Journal of thrombosis and haemostasis - ISSN 1538-7933-21:5 (2023) p. 1266-1273
ProCPU is expressed by (primary) human monocytes and macrophages and expression differs between states of differentiation and activation
Source
International journal of molecular sciences - ISSN 1422-0067-24:4 (2023) p. 1-13
The carboxypeptidase U system in atherosclerosis : insights in carboxypeptidase U mediated pleiotropic effects of statins
Source
Antwerpen, Universiteit Antwerpen, Faculteit Farmaceutische, Biomedische en Diergeneeskundige Wetenschappen, Departement Farmaceutische Wetenschappen, 2022,xv, 289 p.
Activation of the carboxypeptidase U (CPU, TAFIa, CPB2) system in patients with SARS-CoV-2 infection could contribute to COVID-19 hypofibrinolytic state and disease severity prognosis
Source
Journal of Clinical Medicine - ISSN 2077-0383-11:6 (2022) p. 1-11
Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients
Source
Clinica chimica acta - ISSN 0009-8981-531 (2022) p. 4-11